肾移植后反复尿路感染对移植物及患者结局的影响
该回顾性队列研究纳入1999至2014年Barnes-Jewish医院2469例成人肾移植受者,比较无UTI、非反复UTI和反复UTI(R-UTI)的结局。R-UTI与更差的移植物存活和患者存活相关,且多药耐药革兰阴性菌感染风险更高。
要点
- R-UTI定义:任意6个月内≥2次或任意12个月内≥3次UTI。
- R-UTI与更差移植物存活独立相关(校正后HR 2.01)。
- R-UTI与更差患者存活相关(HR 1.87),且多药耐药风险增高。
核心结论
- R-UTI与更差的移植物和患者结局相关,且多药耐药革兰阴性菌感染风险更高。
研究设计与样本
- 回顾性队列研究(1999-2014年),纳入Barnes-Jewish医院2469例成人肾移植受者,排除术后30天内死亡者。
主要发现
- 2469例中,1835例(74.3%)无UTI,465例(18.8%)为非反复UTI,169例(6.8%)为R-UTI。
- R-UTI vs 非反复UTI:移植物存活HR 1.45(95%CI 1.23-1.83,P<0.001);vs 无UTI:HR 2.11(95%CI 2.02-3.80,P<0.001)。
- Cox回归校正混杂因素后,R-UTI与移植物存活HR 2.01(95%CI 1.53-2.66,P<0.001)。
- 无UTI与非反复UTI患者存活无差异(HR 1.21,95%CI 0.91-1.63,P=0.181);R-UTI vs 非反复UTI患者存活HR 1.87(95%CI 1.21-2.89,P=0.005)。
- R-UTI更可能由多药耐药革兰阴性菌引起(风险比1.49,95%CI 1.31-1.70,P<0.001)。
关键数值与推荐
- UTI定义:尿样本细菌菌落形成单位>10^5/mL。
- R-UTI定义:任意6个月内≥2次UTI或任意12个月内≥3次UTI。
临床怎么用
- 肾移植后应重视R-UTI的监测与防治,因其与移植物和患者存活恶化相关。
- 对R-UTI患者需关注多药耐药革兰阴性菌感染风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Urinary tract infections (UTIs) are common following kidney transplantation (KT); however, the influence of recurrent post-KT UTI (R-UTI) is not well-characterized. METHODS: We compared graft outcomes, patient outcomes and multidrug-resistance rates between patients with no UTI, nonrecurrent UTI (NR-UTI) (urine sample containing >105 bacterial colony-forming units/mL) and R-UTI (≥2 UTIs in any 6-month period or ≥3 UTIs in any 12-month period) post-KT in a retrospective cohort study (1999-2014) at Barnes-Jewish Hospital (St Louis, MO). All adult KT recipients were included and those experiencing mortality within 30 days of KT were excluded. RESULTS: Of 2469 recipients included, 1835 (74.3%) had no UTI, 465 (18.8%) had NR-UTI and 169 (6.8%) had R-UTI. R-UTI was associated with poorer graft survival compared with NR-UTI [hazard ratio (HR) 1.45; 95% confidence interval (CI) 1.23-1.83; P < 0.001) and no UTI (HR 2.11; 95% CI 2.02-3.80; P < 0.001). This relationship persisted after adjusting for confounding factors in Cox regression (HR 2.01; 95% CI 1.53-2.66; P < 0.001). There was no difference in patient survival between no UTI and NR-UTI (HR 1.21; 95% CI 0.91-1.63; P = 0.181); however, R-UTI was associated with poorer patient survival compared with nonrecurrent cases (HR 1.87; 95% CI 1.21-2.89; P = 0.005). R-UTI were more likely to be caused by multidrug-resistant Gram-negative organisms (risk ratio 1.49; 95% CI 1.31-1.70; P < 0.001). CONCLUSIONS: R-UTIs were associated with poorer graft and patient outcomes, as well as increased multidrug-resistance compared with nonrecurrent cases.
引用
- Britt NS, Hagopian JC, Brennan DC, et al. Effects of recurrent urinary tract infections on graft and patient outcomes after kidney transplantation. Nephrol Dial Transplant. 2017. PMID: 28967964. doi:10.1093/ndt/gfx237
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。